|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/08 | (2006.01) |
| A61K 31/498 | (2006.01) | ||
| A61P 15/00 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3464288 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17725242.6 |
| Date of filing the European patent application | 2017-05-23 | |
| (97) | Date of publication of the European application | 2019-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-23 |
| (46) | Date of publication of the claims translation | 2021-01-25 |
| (86) | Number | PCT/EP2017/062359 |
| Date | 2017-05-23 |
| (87) | Number | WO 2017/202817 |
| Date | 2017-11-30 |
| (30) | Number | Date | Country code |
| 16171538 | 2016-05-26 | EP | |
| 16178891 | 2016-07-11 | EP |
| (72) |
KOPPITZ, Marcus, DE
SIEBENEICHER, Holger, DE
STEUBER, Holger, DE
TER LAAK, Antonius, DE
NUBBEMEYER, Reinhard, DE
ROTTMANN, Antje, DE
IRLBACHER, Horst, DE
BADER, Benjamin, DE
PETERS, Michaele, DE
WAGENFELD, Andrea, DE
TEREBESI, Ildiko, DE
|
| (73) |
Bayer Pharma Aktiengesellschaft,
Müllerstrasse 178, 13353 Berlin,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | [8-(Fenilsulfonil)-3,8-diazabiciklo[3.2.1]okt-3-il](1H-1,2,3-triazol-4-il)metanonai |
| [8-(PHENYLSULFONYL)-3,8-DIAZABICYCLO[3.2.1]OCT-3-YL](1H-1,2,3-TRIAZOL-4-YL)METHANONES |
| Payment date | Validity (years) | Amount | |
| 2025-04-22 | 9 | 208.00 EUR |
| 2026-05-23 |